March 2017

Retired Armed Forces personnel till 2002 could avail medical facilities only for specific high cost surgery/treatment for a limited number of diseases covered under the Army Group Insurance(Medical Branch Scheme) (AGI(MBS)) and Armed Forces Group Insurance Scheme(Management Information System) (AFGIS (MIS)) schemes. These medicare schemes could provide some relief to the ESM, but it was not a comprehensive scheme as compared to and available for other Central Government Employees. Therefore, the requirement was felt of establishing a medicare system which could provide quality medicare to the retirees of the Armed Forces.

Post : Pharmacist

ITI Limited, the Country's premier Telecom Company & Multi Unit Central Public Sector undertaking is all set to take telecom and IT to greater and unexplored realms. The Company has also emerged as the Country's leading total solutions provider in telecommunications. The company offers complete range of Telecom Products covering the whole spectrum of Switching, Transmission, Access and subscriber premises equipments. In line with the prevailing technology trend, ITI has made strides in CDMA and GSM Technology, manufacture of GSM – BTS and Infrastructure equipment. Besides offering the latest Telecom solutions and customized support to a variety of business, ITI has dedicated network system Unit for carrying out Installation and Commissioning of equipments and for undertaking turnkey Projects. The Company has set up state of the art Data Centre at Bangalore. As per the revival plan, ITI is concentrating more on manufacturing new Products in Defense and Railway sectors and the manufacturing of Solar Equipment, NGN products, GPON, NPR, LED Lighting systems and more.

Post : CHEMIST

{ DOWNLOAD AS PDF }

ABOUT AUTHORS
Amiya Kumar Ghosh*¹,Saptarshi Samajdar², Shiladitya Palit³,  Rupchand Pandit^4
1Department of Pharmaceutical Technology, UTKAL UNIVERSITY, Bhubaneswar- 751004,Odisha, India.
²Centre for Pharmaceutical Sciences and Natural Products, CENTRAL UNIVERSITY OF PUNJAB, Bathinda-151001, Punjab, India
³Department of Pharmaceutics, IITBHU, Varanasi, India
⁴Department of Pharmaceutical Science & Technology, Birla Institute of Technology, Mesra Ranchi-835215, Jharkhand, India
^*amiyaghosh94@gmail.com

ABSTRACT
Tuberculosis (TB) has been declared as a global health emergency by the World Health Organization(WHO). This has been mainly due to the emergence of multiple drug resistant strains and the synergy between tubercle bacilli and the human immunodeficiency virus (HIV). Mycobacterium tuberculosis (Mtb) is a pathogenic bacteria species in the genus Mycobacterium and the causative agent of most cases of tuberculosis. Tuberculosis (TB) is the leading cause of death in the world from a bacterial infectious disease. This antibiotic resistance strain lead to development of the new antibiotics or drug molecules which can kill or suppress the growth of Mycobacterium tuberculosis.The need for new antiTB is persistent due to the emergence of drug resistant Mycobacterium tuberculosis. Here we aimto identify new drug targets in Mycobacterium tuberculosis by phylogenomics among the Mycobacterium tuberculosisandcomparative genomics to Homo sapiens. The proposed target discovery pipeline is largely independent of experimental data and based on the assumption that Mycobacterium tuberculosis proteins are likely to be essential if (i) there are no similar proteins in the same proteome and (ii) they are highly conserved across the Mycobacterium tuberculosisof mammals. We have performed an in silicocomparative analysis of metabolic pathways of the host Homo sapiens and the pathogen Mycobacterium tuberculosis (H37Rv). Novel efforts in developing drugs that target the intracellular metabolismof M. tuberculosis often focus on metabolic pathways that are specific to M. tuberculosis. We have identified five unique pathwaysfor Mycobacterium tuberculosis having a number of 60 enzymes, which are nonhomologous to Homo sapiens protein sequences,and among them there were 55 enzymes, which are nonhomologous to Homo sapiens protein sequences.These enzymes were alsofound to be essential for survival of theMycobacteriumtuberculosisaccording to the DEG database. Further, the functional analysis using Uniprot showed involvement of all the unique enzymes in the different cellular components.

UBM India is India's leading exhibition organizer that provides the industry with platforms that bring together buyers and sellers from around the world, through a portfolio of exhibitions, content led conferences & seminars. UBM India hosts over 20 large scale exhibitions and 40 conferences across the country every year; thereby enabling trade across multiple industry verticals. A UBM Asia Company, UBM India has offices across Mumbai, New Delhi, Bangalore and Chennai. UBM Asia is owned by UBM plc which is listed on the London Stock Exchange. UBM Asia is the leading exhibition organizer in Asia and the biggest commercial organizer in mainland China, India and Malaysia

UBM India the organisers of InnoPack Pharma Confex are pleased to announce the 2nd Edition of India Packaging Awards.  As India’s first & only packaging Awards this initiative is dedicated to honouring the revolutionary and inspiring innovations of radical thinkers of the industry who drive this thriving industry’s success.

This centre which was started by ICMR basically  to solve problems in blood banking, slowly branched out  successfully to initiate research in various other related areas of immunohaematology viz. biochemical genetics,  red cell enzymopathies and hemoglobinopathies,  population genetics, antenatal serology,  Immunology, HLA etc. In the first  twenty five  years,  using limited space, limited  resources  and budget,  talented and highly enthusiastic young  scientists from the  center under the guidance of  dynamic  stalwarts Dr.  H M Bhatia and  Dr. A J Baxi could produce as many as 271  publications  of which 71  were published in prestigious  international  journals.  The  centre had  many discoveries to it’s credit. Seeing this progress, ICMR decided to rechristen BGRC  as ‘Institute  of Immunohaematolgy’ at the time of  the Silver Jubilee Celebrations of the Institute in 1982 to accommodate all the departments of the centre under one roof.

Eligible candidates are invited to apply for written test/Interview for the following temporary post on 3rd April 2017 to be conducted at NIIH (ICMR), Parel, Mumbai.

Applications are invited for the various research position (Purely Temporary) for the DST, sponsored research project in the Department of Pharmaceutical Technology and Centre for Excellence in Nanobio Translational Research (Autonomous), Anna University, Bharathidasan Institute of Technology Campus, Tiruchirappalli, Tamil Nadu. PIN – 620024.

ABOUT AUTHOR
Vinay Kumar Singh.
Chief Research Officer
Parammount Cosmetics India Limited,
Bangalor, Karnataka
vinay@parammount.com

Many articles have been written on Colour Cosmetics. I too have written a few articles on Colour Cosmetics. A M. Tech. student of mine from ICT (formally UDCT of Mumbai University) called me to ask me to send him a write up on Colour Science and its impact on colour cosmetics; which prompted me to write this article which is an amalgam of Basics of colours, science behind colour and its usage in Cosmetics.